Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2007
02/08/2007WO2007015177A2 In vitro diagnostic method and kit for an aspergillus infection
02/08/2007WO2007015170A2 Synapse-specific proteins in glomeruli
02/08/2007WO2007015128A1 DIAGNOSIS, TREATMENT, AND PREVENTION OF VASCULAR DISORDERS USING IL-1α AUTOANTIBODIES
02/08/2007WO2007015054A1 Generation of carbon monoxide for testing sensors and detectors
02/08/2007WO2007014991A1 Antibodies directed against a ldl receptor
02/08/2007WO2007014931A2 Method and system for determining the concentration of an analyte/enzyme complex or of an analyte/enzyme conjugate, especially for the electrochemical detection of the analyte, and corresponding measuring device
02/08/2007WO2007014903A1 Method for detecting a fuel additive component
02/08/2007WO2007014824A1 Fat taste receptors and their methods of use
02/08/2007WO2007014775A1 Method for successively functionalising a substrate and a microstructure is obtainable by said mehtod
02/08/2007WO2007014667A1 In vitro process for diagnosticating neurogenerative diseases
02/08/2007WO2007014475A1 Thread testing appliance
02/08/2007WO2007014467A1 DlAGNOSIS AND TREATMENT OF MOOD DISORDERS
02/08/2007WO2007014463A1 Nalp7-based diagnosis of female reproductive conditions
02/08/2007WO2007014460A1 Cancerous disease modifying antibodies
02/08/2007WO2007014459A1 Cancerous disease modifying antibodies
02/08/2007WO2007014458A1 Cancerous disease modifying antibodies
02/08/2007WO2007014457A1 Cancerous disease modifying antibodies
02/08/2007WO2007014456A1 Cancerous disease modifying antibodies
02/08/2007WO2007014455A1 Cancerous disease modifying antibodies
02/08/2007WO2007014442A1 Quality fuel analyser
02/08/2007WO2007014434A1 Biomarker for cardiovascular disease
02/08/2007WO2007014420A1 Method for identifying regulatory t cells
02/08/2007WO2006131599A3 Method of profiling a cell population
02/08/2007WO2006129007A3 Quantification of total silicon in biogas
02/08/2007WO2006127517A3 Pretreatment of a biological sample from an autoimmune disease subject
02/08/2007WO2006125050A3 Biobarcode assays for ultra high sensitive detection
02/08/2007WO2006116708A3 Method of minimizing reagent consumption in microplate-based reactions
02/08/2007WO2006105111A3 Colloidal metal conjugates
02/08/2007WO2006096468A3 Enhanced detection of biological and bioactive components by resonance raman spectroscopy
02/08/2007WO2006095330A3 Methods and immunogenic cell preparations for treating antigen-associated diseases
02/08/2007WO2006094293A3 Slim compositions and methods of use thereof
02/08/2007WO2006093932A3 Use of eotaxin as a diagnostic indicator for atherosclerosis and vascular inflammation
02/08/2007WO2006091734A3 Compositions and methods for classifying biological samples
02/08/2007WO2006088576A3 Polypeptide formulations and methods for making, using and characterizing them
02/08/2007WO2006081308A3 Plasmodium diagnostic assay device
02/08/2007WO2006079071A3 Methods and compositions related to tr4
02/08/2007WO2006078422A3 Methods for modulating tumor growth and metastasis
02/08/2007WO2006076584A3 Kid31 and antibodies that bind thereto
02/08/2007WO2006071895A3 Nanoelectronic devices for dna detection, and recognition of polynucleotide sequences
02/08/2007WO2006066598A3 Antibody binding affinity ligands
02/08/2007WO2006065762A3 Surface enhanced raman spectroscopy using shaped gold nanoparticles
02/08/2007WO2006062732A3 Compounds acting at the centrosome
02/08/2007WO2006060484A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
02/08/2007WO2006055502A9 Method of analyzing basestocks for low temperature properties
02/08/2007WO2006052822A3 Methods and devices for screening cervical cancer
02/08/2007WO2006052718A8 Farnesyltransferase inhibitors for treating sepsis
02/08/2007WO2006050532A3 Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof
02/08/2007WO2006048886A3 Laboratory devices, methods and systems employing acoustic ejection devices
02/08/2007WO2006042109A3 An apparatus for and method of sampling and collecting powders flowing in a gas stream
02/08/2007WO2006026717A3 Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
02/08/2007WO2006000107A8 Fibre monitoring apparatus and method
02/08/2007WO2005111611A3 Methods and apparatus for facilitating analysis of large data sets
02/08/2007WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
02/08/2007WO2005006881A3 Salt taste modification
02/08/2007WO2005001049A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins
02/08/2007WO2004072260A3 Cell free assay systems for identifying a substance of interest
02/08/2007US20070033669 Semaphorin gene family
02/08/2007US20070033660 Method for selectively destroying dividing cells
02/08/2007US20070032997 Disease simulation system and method
02/08/2007US20070032964 Method to determine predictive tests and device applying same to lubricant formulations
02/08/2007US20070032963 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program
02/08/2007US20070032962 Method and system for designing proteins and protein backbone configurations
02/08/2007US20070032960 Data transmission to a position sensor
02/08/2007US20070032672 reacting acyclic unsaturated aldehydes with ethyl orthoformate, in the presence of catalysts, then reacting with triethoxysilane, reduction and oxidation to form omega-silanyl aldehydes, used in the fuctionalization of solid supports, used for biochemical immobilization and/or biosynthesis
02/08/2007US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
02/08/2007US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032637 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity
02/08/2007US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
02/08/2007US20070032572 Films with optical clarity, wear resistance and superior performance with nanofillers and polymers for thin films
02/08/2007US20070032553 Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome
02/08/2007US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
02/08/2007US20070032423 Methods and compositions for modulating somatolactogenic functions
02/08/2007US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins
02/08/2007US20070032414 Human secreted proteins
02/08/2007US20070032413 Of given amino acid sequence; vectors, host cells, and recombination; diagnosing and treating diseases related to human secreted proteins
02/08/2007US20070032403 Crystal structure of the ITK kinase domain
02/08/2007US20070032052 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors, and fabricating such devices
02/08/2007US20070032051 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors, and fabricating such devices
02/08/2007US20070032023 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors, and fabricating such devices
02/08/2007US20070031980 Method for the controlled transport of magnetic beads
02/08/2007US20070031979 Protein biopolymer markers predictive of type II diabetes
02/08/2007US20070031978 For performing an immunochromatographic analysis including a porous substrate for a visually detectable indicator that binds to material to be tested for performing the analysis and a pre-filter to remove solid components, such as suspended organic material, to prevent blocking of the substrate
02/08/2007US20070031973 Triazine derivatives as universal peptide isotope tag reagents (U-PIT)
02/08/2007US20070031972 Detection of poisons in materials such as food using colorimetric detection
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031961 Biosensors and methods for their use
02/08/2007US20070031956 Crystal structure of human PIM-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
02/08/2007US20070031940 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
02/08/2007US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
02/08/2007US20070031929 Polypeptides Homologous To VEGF and BMP1
02/08/2007US20070031911 Isotopically-labeled proteome standards
02/08/2007US20070031910 Method of stabilizing sample
02/08/2007US20070031908 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
02/08/2007US20070031907 Anaplastic lymphoma kinase assay, reagents and compositions thereof
02/08/2007US20070031906 Test system for detecting salmonella
02/08/2007US20070031905 Soluble fas urinary marker for the detection of bladder transitional cell carcinoma
02/08/2007US20070031904 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031903 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031902 Predictive Methods For Cancer Chemotherapy